SSH - FORT MYERS — History
CCN 102029 | 3-year financial timeline | COVID resilience: 37/100
🛡️ Public data only — no PHI permitted on this instance.
$27M
Latest Revenue (FY2022)
+1.3%
Revenue CAGR (3yr)
-1.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $27M | $27M | $27M | -0.7% | +1.3% |
| Operating Expenses | $25M | $29M | $28M | -3.0% | +5.8% |
| Operating Margin | 6.7% | -4.4% | -1.9% | +57.1% | +0.0% |
| Net Income | $2M | $-1M | $-1M | +57.4% | +0.0% |
| Licensed Beds | 60 | 60 | 60 | +0.0% | +0.0% |
| Total Patient Days | 16,586 | 16,837 | 15,519 | -7.8% | -3.3% |
| Medicare Day % | 49% | 44% | 53% | +19.6% | +4.3% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 37/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +2.6% ($27M → $27M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+1.3%
This Hospital
+7.6%
State Avg
Latest Margin
-1.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $28M | -6.2% |
| FY2024 (proj) | $28M | -10.5% |
| FY2025 (proj) | $28M | -14.8% |